期刊文献+

比卡鲁胺的合成 被引量:3

Synthesis of Bicalutamide
下载PDF
导出
摘要 以环氧化合物1,2-环氧-2-甲基-N-[4-氰基-3-(三氟甲基)苯基]丙酰胺为起始原料,经缩合、氧化两步反应制得非甾体类抗雄激素药物比卡鲁胺。对中间体的合成工艺进行了改进。以二甲基甲酰胺为溶剂、四丁基溴化铵为相转移催化剂、碳酸钾为缚酸剂,使反应无需控制水分,并可在温和条件下进行,反应收率由文献的67.8%提高到88.9%。 A nonsteroidal antiandrogen drug,bicalutamide,was synthesized starting from N-[4-cyano3-(trifluoromethyl)phenyl]-1,2-epoxy-2-methylpropionamide via two steps of condensation and oxidation.The synthetic process of the intermediate was improved.The condensation reaction needed not control moisture,and could take place under a mild condition by using DMF as solvents,TBAB as a phase transfer catalyst,and K2CO3 as an acid binding agent.The yield was up to 88.9% from 67.8%.
出处 《浙江化工》 CAS 2013年第6期7-9,共3页 Zhejiang Chemical Industry
关键词 比卡鲁胺 合成 非甾体抗雄激素 bicalutamide synthesis nonsteroidal antiandrogen
  • 相关文献

参考文献7

  • 1Sepp-Loreno L, Slovin S. Prostate cancer: therapeutic patent review [J]. Exp Opin Ther Patents, 2000, 10(12): 1833-1842.
  • 2Thurlow R J. Treatment options for benign prostatic hyperplash [J]. Emerging Drugs, 1998, 3(1): 225-246.
  • 3Macclesfield T H. Amide derivatives:EP,0100172 [P], 1984-02-08.
  • 4刘雅茹,冯雪松,孟繁浩,刘俊亭.抗雄激素药物比卡鲁胺的合成[J].中国医科大学学报,2005,34(6):518-519. 被引量:8
  • 5Tetsuya S, Tadashi K, Kiyoshi S, et al. Method for producing biealutamide : WO,2005037777A1 [P], 2005- 04-28.
  • 6Tucker H, Crook J W, Chesterson G J. Synthesis and structure -activity relationships of 3 -substituted derivatives of 2-hydroxy propionanilides [J]. J Med Chem, 1988, 31(5): 954-959.
  • 7季华,乐园,沈志刚,陈建峰.反溶剂重结晶法制备多晶型比卡鲁胺[J].北京化工大学学报(自然科学版),2008,35(4):14-17. 被引量:7

二级参考文献10

  • 1Howard T,Crook JW,Chesterson GJ.Nonsteroidal antiandrogens.Synthesis and structure activity relationships of 2-hydroxypropionanilides[J].Med Chem,1988,31 (5):954-959.
  • 2Goa KL,Spencer CM.Bicalutamide in advanced prostate cancer[J].A Review Drugs Aging,1998,12(5):401-422.
  • 3Howard T,Chesterson GJ.Resolution and activity of enantiomers[J].Med Chem,1988,31 (4):885-887.
  • 4Mebee ET,Lowery OR,Some Dihalo-(trifluoromethyl)-benzenes[J].J Am Chem Soc,1951,73(23):3932-3936.
  • 5Yu Z Q, Tan R H B, Chow P S. Effect of operating conditions on agglomeration and habit of paracetamol crystals in anti-solvent crystallization[J]. Journal of Crystal Growth, 2005, 279(3 - 4) : 477 - 488.
  • 6Vippagunta S R, Brittain H G, Grant D J W. Crystalline solids[J]. Advanced Drug Delivery Reviews, 2001, 48: 3 - 26.
  • 7Wirth M P, Hakenberg O W, Froehner M. Antiandrogens in the treatment of prostate cancer [ J ]. European Urology, 2006, 51(2): 306 - 314.
  • 8Vega D R, Polla G, Martinez A, et al. Conformational polymorphism in bicalutamide [ J ]. International Journal of Pharmaceuticals, 2006, 328(2) : 112 - 118.
  • 9Westheim R J H, Nijmegen. Bicalutamide forms: US, 0063782 A1[P], 2004-04-01.
  • 10Jenkins S, Liversidge G. Nanoparticulate biealutamide formulations: US, 0159767 A1[P], 2006-06-20.

共引文献13

同被引文献18

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部